# CE Mark Study for the Harpoon Medical Device

> **NCT02768870** · NA · COMPLETED · sponsor: **Edwards Lifesciences** · enrollment: 26 (actual)

## Conditions studied

- Mitral Valve Regurgitation
- Mitral Valve Prolapse
- Mitral Valve Insufficiency

## Interventions

- **DEVICE:** Harpoon Artificial ePTFE Chords

## Key facts

- **NCT ID:** NCT02768870
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-28
- **Primary completion:** 2017-11-06
- **Final completion:** 2022-09-06
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2024-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02768870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02768870, "CE Mark Study for the Harpoon Medical Device". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02768870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*